Nothing you've said seems wrong to me, but the tone of how you write is too dismissive.
> since there are other explanations (lifestyle habits, genetics, poverty) that would explain the difference, in whole or in part.
This doesn't contradict the meaning of "structural, systemic racism", but it explains it. When pharmacies are making drugs that are only effective for white people, and not researching effectiveness on black people, that's structural racism almost by definition.
Obviously pharma companies are responding to financial incentives, and if it's not profitable for a company to research treatments specifically helping a minority group then they're probably not going to. Less availability of pharmaceuticals makes treatment harder, causing what is available more expensive or leading to complications that require more further medical treatment (and cost more money); and those who choose not to get treatment will find themselves with further medical conditions later. In the end it would cost the minority more money, which they likely cannot pay for other systemic reasons, so more often they would be denied access to a hospital outright. Everyone involved is responding to natural incentives, but the net result still becomes [minority group] is neglected because of the color of their skin.
> Did you read the whole comment?
When you write like this it feels like you're attacking the character of the person you're talking to, which makes the whole conversation more toxic to follow.
> since there are other explanations (lifestyle habits, genetics, poverty) that would explain the difference, in whole or in part.
This doesn't contradict the meaning of "structural, systemic racism", but it explains it. When pharmacies are making drugs that are only effective for white people, and not researching effectiveness on black people, that's structural racism almost by definition.
Obviously pharma companies are responding to financial incentives, and if it's not profitable for a company to research treatments specifically helping a minority group then they're probably not going to. Less availability of pharmaceuticals makes treatment harder, causing what is available more expensive or leading to complications that require more further medical treatment (and cost more money); and those who choose not to get treatment will find themselves with further medical conditions later. In the end it would cost the minority more money, which they likely cannot pay for other systemic reasons, so more often they would be denied access to a hospital outright. Everyone involved is responding to natural incentives, but the net result still becomes [minority group] is neglected because of the color of their skin.
> Did you read the whole comment?
When you write like this it feels like you're attacking the character of the person you're talking to, which makes the whole conversation more toxic to follow.